AUSTINPX
Edward M. Rudnic is the President and Chief Executive Officer of DisperSol Technologies. For inquiries, telephone and contact numbers are used.
AUSTINPX
Social Links:
Industry:
Manufacturing Pharmaceutical
Founded:
2007-01-01
Address:
Georgetown, Texas, United States
Country:
United States
Website Url:
http://www.austinpx.com
Total Employee:
11+
Status:
Active
Contact:
+1 512-686-4740
Email Addresses:
[email protected]
Total Funding:
57.97 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Pound Sterling Japanese Yen Apple ICloud Mail ENom DNS OpenSRS
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Rapid Micro Biosystems
Rapid Micro Biosystems offers tools that detect microbial contamination in manufacturing pharmaceutical, biotechnology and other products.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Trendvision Technology ( Zhuhai ) Co., Ltd
Trendvision Technology is a professional ink manufacturing company.
Current Employees Featured
Founder
Investors List
Research Corporation Technologies
Research Corporation Technologies investment in Venture Round - AustinPx
Acadia Woods Partners
Acadia Woods Partners investment in Venture Round - AustinPx
Research Corporation Technologies
Research Corporation Technologies investment in Venture Round - AustinPx
Newest Events participated
Participated in 6th Drug Formulation, Solubility & Bioavailability
on 2017-03-27 as sponsor
Key Employee Changes
Official Site Inspections
http://www.austinpx.com Semrush global rank: 15.61 M Semrush visits lastest month: 2
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "AustinPx"
Management Team - AustinPx
Ms. Hickman brings more twenty years of pharmaceutical contract development and manufacturing organization (CDMO) leadership experience to AustinPx. Prior to being named …See details»
AustinPx
AustinPx represents where we come from and what we do. Px stands for Pharmaceutics. To our core, we are a pharmaceutics company. Our approach is data-driven and technology-nonbiased, which means our formulation strategy …See details»
AustinPx - Crunchbase Company Profile
AustinPx closed its last funding round on Oct 16, 2020 from a Venture - Series Unknown round. Who are AustinPx 's …See details»
Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO
GEORGETOWN, TX., March 5, 2024 — AustinPx, developers of the next generation amorphous dispersion platform, KinetiSolâ„¢ Technology, and a contract development and manufacturing …See details»
AustinPx Company Overview, Contact Details & Competitors
AustinPx, LLC. hired Marshall Crew as independent members of board of directors on Oct 1st '22. AustinPx, Pharmaceutics and Manufacturing, a contract development and manufacturing …See details»
Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO - Yahoo …
GEORGETOWN, Texas, March 05, 2024--AustinPx, developers of the next generation amorphous dispersion platform, KinetiSolâ„¢ Technology, and a contract development and …See details»
AustinPx - Overview, News & Similar companies | ZoomInfo.com
Mar 4, 2024 AustinPx Invests in Pharmaceutics and Manufacturing Capabilities to Accelerate Drug Development GEORGETOWN, Texas--(BUSINESS WIRE)--AustinPx, a leading contract …See details»
AustinPx Company Profile - Office Locations, Competitors ... - Craft
AustinPx (formerly Dispersol Technologies) is a company that focuses on formulation and processing technologies for solubility and bioavailability enhancement of poorly water-soluble …See details»
AustinPx Company Profile 2025: Valuation, Funding
AustinPx General Information Description. Operator of a contract development and manufacturing organization intended for analytical and formulation development services and cGMP manufacturing for small molecule drugs.See details»
Kinetisol – AustinPx
Since 2007, AustinPx has been developing the KinetiSol Technology to address the need of improving bioavailability of poorly soluble drugs. A fusion-based, solvent-free process …See details»
AustinPx’s Competitors, Revenue, Number of Employees, Funding …
AustinPx’s Profile, Revenue and Employees. AustinPx is a Texas-based contract development and manufacturing organization that provides services such as formulation development and …See details»
AustinPx – Contract Pharma
Contract Development and Manufacturing Organization (CDMO) 286. Contract Manufacturing 333. Contract Packaging 125. Contract Research 230. Contract Sales Organizations 12. …See details»
ABOUT AUSTINPX - outsourcedpharma.com
About austinpx Founded in 2007, AustinPx is a fee-for-service CDMO offering preclinical through Phase II formulation and process development and GMP manufacturing of oral dosage forms. …See details»
Pharma Matters Q&A: AustinPx – Contract Pharma
Jul 29, 2024 AustinPx is a Georgetown, Texas-based contract development and manufacturing organization (CDMO) founded in 2007 to help developers overcome obstacles in bringing a …See details»
AustinPx Names Derek Hennecke and Marshall Crew to its Board …
Austin, TX, October 18, 2022 — AustinPx, Pharmaceutics and Manufacturing, a contract development and manufacturing organization (CDMO), today announced the appointment of …See details»
AustinPx Expands Development and Manufacturing Technologies
May 9, 2023 AustinPx, Pharmaceutics and Manufacturing, is a contract development and manufacturing organization (CDMO) providing analytical and formulation development …See details»
AustinPx Wins Accelerating Innovation Award for KinetiSol™ …
AUSTIN, Texas, October 22, 2024--AustinPx, developers of the next-generation amorphous dispersion platform, KinetiSolâ„¢ Technology, and a contract development and manufacturing …See details»
Articles - AustinPx
In a recent article, Chris Brough, CTO of AustinPx, highlights KinetiSol Technology as a superior alternative to spray drying for amorphous solid dispersions (ASDs). Unlike spray drying, which …See details»
AustinPx - PharmaSource
AustinPx is a contract development and manufacturing organisation (CDMO) that assists pharmaceutical developers in maximising the potential of their drug candidates. Founded to …See details»
AustinPx Invests in Pharmaceutics and Manufacturing Capabilities …
GEORGETOWN, TX., April 5, 2024 — AustinPx, a leading contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally …See details»